Physician
Popa, Carmen
Popa, Carmen was paid $184K by Medicaid between Jan 2018 and Jul 2024, across 73 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 20% of everything it billed.
33Billing provider infoPOPA, CARMEN
PARMA HEIGHTS, OH 44130
PARMA HEIGHTS, OH 44130
33aNPI1841385119assigned 10/04/2006
33bProvider typeInternal Medicine Physician
28Total paid$184K
24GClaims13,170
24DCodes billed73
24AFirst – last monthJan 2018 – Jul 2024
Compared with peers
Next to other Internal Medicine Physician providers in Ohio
Rank by total paid#151 of 663
Median peer was paid$17K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 382 | $11K | |
| 2024incomplete | 12,788 | $173K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 600 | 534 | $37K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 658 | 454 | $28K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 9.3% | 332 | 167 | $17K |
| 96375 | Therapeutic injection; each additional sequential IV push | 8.1% | 293 | 143 | $15K |
| 99442 | 4.7% | 203 | 175 | $9K | |
| 99051 | 4.1% | 373 | 309 | $8K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.7% | 83 | 81 | $7K |
| 83880 | 2.9% | 224 | 177 | $5K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.3% | 225 | 219 | $4K |
| J3490 | Unclassified drugs | 2.1% | 567 | 142 | $4K |
| 80305 | 1.9% | 386 | 380 | $4K | |
| 80053 | Comprehensive metabolic panel | 1.7% | 408 | 283 | $3K |
61 more codes
| 84443 | Thyroid stimulating hormone (TSH) | 1.3% | 229 | $2K |
| 82784 | 1.3% | 129 | $2K | |
| 82607 | 1.2% | 217 | $2K | |
| 82746 | 1.1% | 216 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 374 | $2K |
| 82728 | 1.0% | 210 | $2K | |
| 36415 | Collection of venous blood by venipuncture | 1.0% | 563 | $2K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 115 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 106 | $2K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 32 | $2K |
| 80061 | Lipid panel | <1% | 192 | $2K |
| 99441 | <1% | 59 | $2K | |
| 83735 | <1% | 335 | $2K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 39 | $1K |
| 83550 | <1% | 226 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 231 | $1K |
| 83540 | <1% | 226 | $974.96 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 81 | $894.73 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 326 | $825.73 |
| 82552 | <1% | 92 | $761.58 | |
| 84436 | <1% | 213 | $674.51 | |
| 83874 | <1% | 91 | $671.22 | |
| J2300 | Injection, nalbuphine hydrochloride, per 10 mg | <1% | 206 | $551.38 |
| 99050 | <1% | 28 | $484.41 | |
| 85049 | <1% | 164 | $466.93 | |
| 80051 | <1% | 126 | $443.80 | |
| 84484 | <1% | 92 | $418.50 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 170 | $415.71 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 301 | $390.50 |
| 82550 | <1% | 92 | $380.22 | |
| 93000 | <1% | 32 | $379.86 | |
| 84460 | <1% | 140 | $356.19 | |
| 84075 | <1% | 141 | $348.50 | |
| 84450 | <1% | 140 | $347.85 | |
| 82310 | <1% | 139 | $342.05 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 31 | $337.28 |
| 82565 | <1% | 139 | $335.45 | |
| 82247 | <1% | 139 | $333.47 | |
| 82040 | <1% | 140 | $332.22 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 227 | $325.08 |
| 99401 | <1% | 12 | $312.53 | |
| 83690 | <1% | 104 | $296.57 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 188 | $269.64 |
| 84520 | <1% | 138 | $255.65 | |
| 85018 | <1% | 163 | $246.38 | |
| 84155 | <1% | 140 | $246.21 | |
| 85014 | <1% | 163 | $244.51 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 26 | $217.55 |
| 85041 | <1% | 114 | $201.84 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 55 | $175.97 |
| 85048 | <1% | 104 | $149.96 | |
| 82553 | <1% | 87 | $145.44 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 149 | $121.84 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 254 | $91.66 |
| 82150 | <1% | 105 | $90.36 | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 73 | $86.95 |
| 81003 | <1% | 43 | $70.48 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 92 | $24.00 |
| 99408 | <1% | 12 | $15.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 24 | $8.74 |
| J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg | <1% | 23 | $2.99 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.